MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 591813 | Name: Phenoxyacetone
Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Phenoxyacetone causes Acetylcholinesterase inhibition.

Chemical Structure

Phenoxyacetone
Phenoxyacetone
CAS#621-87-4

Theoretical Analysis

MedKoo Cat#: 591813

Name: Phenoxyacetone

CAS#: 621-87-4

Chemical Formula: C9H10O2

Exact Mass: 150.0681

Molecular Weight: 150.18

Elemental Analysis: C, 71.98; H, 6.71; O, 21.31

Price and Availability

Size Price Availability Quantity
5g USD 220.00
Bulk Inquiry
Buy Now
Add to Cart
Related CAS #
No Data
Synonym
Phenoxyacetone; NSC 1876; NSC-1876; NSC1876
IUPAC/Chemical Name
2-Propanone, 1-phenoxy-
InChi Key
QWAVNXZAQASOML-UHFFFAOYSA-N
InChi Code
InChI=1S/C9H10O2/c1-8(10)7-11-9-5-3-2-4-6-9/h2-6H,7H2,1H3
SMILES Code
CC(COC1=CC=CC=C1)=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.03.00
More Info
Product Data
Product Data
Instruction
View handling instruction
Biological target:
Phenoxyacetone causes Acetylcholinesterase inhibition.
In vitro activity:
TBD
In vivo activity:
TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 150.18 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
TBD
In vitro protocol:
TBD
In vivo protocol:
TBD
1: Dafforn A, Neenan JP, Ash CE, Betts L, Finke JM, Garman JA, Rao M, Walsh K, Williams RR. Acetylcholinesterase inhibition by the ketone transition state analog phenoxyacetone and 1-halo-3-phenoxy-2-propanones. Biochem Biophys Res Commun. 1982 Jan 29;104(2):597-602. PubMed PMID: 7073703. 2: Landquist JK. Oxidative cyclisation of ketone thiosemicarbazones. II. Derivatives of phenoxyacetone. J Chem Soc Perkin 1. 1970;2:323-4. PubMed PMID: 5460862.